Hemophilia B Gene Therapy Sustains Efficacy Over a Decade Later

(MedPage Today) — A single infusion of adeno-associated virus (AAV)-mediated gene therapy led to sustained clinical benefit and no late-onset safety concerns in patients with severe hemophilia B, a longitudinal study showed.
At a median follow…